LONDON, September 30 (Reuters): Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients -
New Delhi, September 26 (IANSlife): In the last eight months of the Coronavirus pandemic, enough cases have been made for supplementing Covid-19 treatment with natural medicine. Data emerging from multiple loca
ZURICH, July 26 (Reuters): Novartis's Sandoz division will not profit from 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19 for the pandemic's duration,
CHENNAI, JULY 15 (IANS): The Insurance Regulatory and Development Authority (IRDAI) has asked insurers to take action against hospitals that decline cashless treatment facility for Covid-19 to policyholders.
LONDON/GENEVA, June 18 (Reuters): Large multi-country trials of the combination HIV drug lopinavir/ritonavir to treat COVID-19 have recruited thousands of patients and the World Health Organization is now
Reuters
The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among U.S. doctors, who said the recent withdrawal of an influential COVID-19 st
Trial results announced on Tuesday showed dexamethasone, which is used to reduce inflammation in other diseases such as arthritis, reduced death rates by around a third among the most severely ill of COVID-19 p
SINGAPORE, June 10 (Reuters): Singapore's Tychan, a biotechnology firm backed by state investor Temasek Holdings, said it will begin human clinical trials next week for a potential monoclonal antibody